// App-Quantinova.ai

Sa2057 : Lactoferrin Enhances Intestinal Barrier Function by Counteracting Oxidative Stress and Inflammation While Upregulating Tight Junction Protein Expression and Lowering Permeability in CaCO-2/15 Cells

Researchers

Presenter

  • Ernest G. Seidman

Principal Investigators

  • Carole Garofalo

  • Schohraya Spahis

  • Valerie Marcil

  • Yves Pouliot

  • Jean-Francois Beaulieu

  • Emile Levy

Medical Centers

  • Research Center CHU Sainte Justine, Montreal, QC, Canada

  • Anatomy & Cell Biology, Universite de Sherbrooke, Sherbrooke, Quebec, Canada

  • Research Institute, McGill University, Quebec, QC, Canada

  • School of Rehabilitation, University of Montreal, Montreal, QC, Canada

  • Institute of Nutrition and Functional Foods, Universite Laval, Quebec City, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

  • Prostaglandin E2

  • Lactotransferrin

Drug/Treatment

  • Fluorescein sodium

  • Lactoferrin

  • Occlusal-HP Topical

  • Dex-HEMA

  • Dinoprostone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved